AnaSantos Rutschman
Vaccines as Technology: Innovation, Barriers, and the Public Health
Vaccines as Technology: Innovation, Barriers, and the Public Health
YOU SAVE £5.20
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Couldn't load pickup availability
Excellent- More about Vaccines as Technology: Innovation, Barriers, and the Public Health
The COVID-19 pandemic has highlighted the need for effective vaccine development and distribution. This book explores the entire arc of vaccine development and distribution, covering key concepts and problems in vaccine regulation, intellectual property, technology transfer, and international relations. It also analyzes the impact of COVID-19 and covers other vaccine races and future directions.
Format: Hardback
Length: 250 pages
Publication date: 14 April 2022
Publisher: Cambridge University Press
The COVID-19 pandemic has served as a stark reminder of our collective responsibility to develop and distribute new vaccines efficiently and equitably, alongside the widespread administration of existing ones. The current models of vaccine production and allocation, primarily driven by market-based mechanisms, fail to adequately meet the urgent public health needs. This groundbreaking book is the first to comprehensively explore the entire journey of vaccine development and distribution, encompassing critical aspects such as allocation of research and development (R&D) funds, the administration of vaccines derived from R&D efforts, vaccine regulation, intellectual property, technology transfer, and international relations. By presenting complex concepts and challenges in a user-friendly manner, the book aims to make vaccine-related knowledge accessible to a broad audience, including non-specialists.
In its analysis of the impact of COVID-19, the book also delves into several other vaccine races and explores potential future directions in vaccine development and allocation. It sheds light on the challenges and opportunities faced by countries in their efforts to combat emerging pathogens and ensure global health security.
The COVID-19 pandemic has underscored the urgent need for a paradigm shift in vaccine development and distribution. By recognizing the limitations of current approaches and embracing a more holistic and collaborative approach, we can strive to create a more resilient and equitable global health system. This book serves as a valuable resource for policymakers, researchers, healthcare professionals, and anyone interested in understanding the complexities of vaccine development and distribution.
Weight: 444g
Dimension: 229 x 152 x 13 (mm)
ISBN-13: 9781009123396
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
